DRTG(SH:600329) Xin Lang Cai Jing·2025-11-03 03:45Core Insights - Daren Tang's stock price has increased by 56.00% year-to-date, with a 7.42% rise in the last five trading days and an 18.81% increase over the past 60 days [2] Company Overview - Daren Tang, established on December 29, 1981, and listed on June 6, 2001, is located in Tianjin, China. The company operates in various sectors including traditional Chinese medicine, drug retail, and biopharmaceuticals [2] - The main revenue sources for Daren Tang are traditional Chinese medicine (91.47%), other main income (6.54%), Western medicine (1.77%), and other (0.22%) [2] - As of September 30, 2025, the number of shareholders has increased by 7.46% to 58,600, while the average circulating shares per person decreased by 6.94% to 9,675 shares [2] Financial Performance - For the period from January to September 2025, Daren Tang reported a revenue of 3.67 billion yuan, a year-on-year decrease of 34.59%. However, the net profit attributable to shareholders increased by 167.73% to 2.15 billion yuan [2] - The company has distributed a total of 5.12 billion yuan in dividends since its A-share listing, with 2.83 billion yuan distributed over the past three years [3] Shareholder Structure - As of September 30, 2025, Hong Kong Central Clearing Limited is the ninth largest circulating shareholder with 4.9954 million shares, an increase of 533,000 shares from the previous period. Meanwhile, the Southern CSI 500 ETF is the tenth largest shareholder with 4.1383 million shares, a decrease of 84,500 shares [3]